• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.

作者信息

Brenchley Paul E C

机构信息

Renal Research Labs, Manchester Royal Infirmary and Institute of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom

出版信息

J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24.

DOI:10.1681/ASN.2015020181
PMID:25804283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4587708/
Abstract
摘要

相似文献

1
Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.抗磷脂酶A2受体抗体与膜性肾病的免疫抑制：抗磷脂酶A2受体自身抗体致病性的更多证据
J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24.
2
Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.利妥昔单抗对伴有抗磷脂酶A2受体抗体滴度持续升高的膜性肾病进行再治疗。
Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045.
3
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.抗磷脂酶A2受体抗体滴度可预测利妥昔单抗治疗后膜性肾病的疗效。
J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24.
4
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.在膜性肾病临床表现出现之前，血清抗磷脂酶A2受体（PLA2R）抗体可能已经存在。
Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032.
5
Treating primary membranous nephropathy with extremely high titer of anti-phospholipase A2 receptor antibodies: A case of failed treatment with very high-dose rituximab.用极高滴度抗磷脂酶A2受体抗体治疗原发性膜性肾病：1例大剂量利妥昔单抗治疗失败的病例
Clin Nephrol. 2025 Jan;103(1):63-68. doi: 10.5414/CN111228.
6
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.磷脂酶A2受体（PLA2R）抗体相关膜性肾病的免疫缓解：环磷酰胺与利妥昔单抗对比
Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019.
7
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.磷脂酶 A2 受体 1 表位在基线时的扩展预示着膜性肾病缓解的可能性降低。
J Am Soc Nephrol. 2018 Feb;29(2):401-408. doi: 10.1681/ASN.2017070734. Epub 2017 Nov 7.
8
Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.肾移植后与磷脂酶A2受体相关的复发性膜性肾病并成功接受利妥昔单抗治疗：一例报告
Transplant Proc. 2018 Oct;50(8):2565-2568. doi: 10.1016/j.transproceed.2018.03.083. Epub 2018 Mar 19.
9
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.两种不同免疫抑制方案治疗的特发性膜性肾病患者中M型磷脂酶A2受体抗体滴度动态变化的预后价值
Biomarkers. 2015 Feb;20(1):77-83. doi: 10.3109/1354750X.2014.993708. Epub 2014 Dec 18.
10
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.抗磷脂酶 A2 受体 1 抗体和抗胱氨酸丰富域抗体在膜性肾病中的识别作用及利妥昔单抗疗效：一项前瞻性队列研究。
Am J Kidney Dis. 2024 May;83(5):588-600.e1. doi: 10.1053/j.ajkd.2023.10.013. Epub 2023 Dec 25.

引用本文的文献

1
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.贝利尤单抗对原发性膜性肾病蛋白尿和抗磷脂酶 A2 受体自身抗体的影响。
Nephrol Dial Transplant. 2020 Apr 1;35(4):599-606. doi: 10.1093/ndt/gfz086.
2
The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis.磷脂酶A2受体自身抗体对特发性膜性肾病患者自发缓解的预后价值：一项荟萃分析。
Medicine (Baltimore). 2018 Jun;97(23):e11018. doi: 10.1097/MD.0000000000011018.
3
Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis.血清抗磷脂酶A2受体自身抗体和肾小球磷脂酶A2受体抗原对诊断特发性膜性肾病的诊断试验准确性：一项更新的荟萃分析
Front Med (Lausanne). 2018 Apr 26;5:101. doi: 10.3389/fmed.2018.00101. eCollection 2018.

本文引用的文献

1
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.抗磷脂酶A2受体抗体滴度可预测利妥昔单抗治疗后膜性肾病的疗效。
J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24.
2
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.特发性膜性肾病中的含血小板反应蛋白1型结构域7A
N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.
3
Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.在原发性膜性肾病中鉴定出被PLA2R自身抗体识别的主要表位。
J Am Soc Nephrol. 2015 Feb;26(2):302-13. doi: 10.1681/ASN.2014050502. Epub 2014 Oct 6.
4
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.原发性膜性肾病患者的M型磷脂酶A2受体自身抗体与肾功能
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.
5
PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes.PLA2R 相关膜性肾小球病受 PLA2R1 和 HLA-DQA1 基因常见变异的调节。
Genes Immun. 2014 Dec;15(8):556-61. doi: 10.1038/gene.2014.50. Epub 2014 Sep 4.
6
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.抗磷脂酶A₂受体（PLA₂R）抗体与特发性膜性肾病免疫抑制治疗后结局的关联
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17.
7
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.磷脂酶 A2 受体自身抗体与原发性膜性肾病患者的临床结局。
J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.
8
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.HLA-DQA1 和 PLA2R1 多态性与特发性膜性肾病的风险。
Clin J Am Soc Nephrol. 2014 Feb;9(2):335-43. doi: 10.2215/CJN.05310513. Epub 2013 Nov 21.
9
Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.PLA2R1 与 HLA-DQA1 变异体的相互作用与抗 PLA2R 抗体和膜性肾病相关。
J Am Soc Nephrol. 2013 Jul;24(8):1323-9. doi: 10.1681/ASN.2012080771. Epub 2013 Jun 27.
10
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.原发性膜性肾病中人 M 型磷脂酶 A2 受体自身抗体的酶联免疫吸附测定法的建立。
Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.